Newsletter - October 13, 2022
Double-Blinding Author Names Suggested to Address Bias in Peer-Review
Reviewers of papers submitted to journals can be biased towards authors with established credentials; for example, an article with a Nobel Laurette as an author is about 6 times more likely to get published without any significant comments compared to one by novice authors. This can be addressed by anonymizing the...Read More
Harmonization of Clinical Trial Rules for Private and Public Funded Clinical Trials
Reviewers of papers submitted to journals can be biased towards authors with established credentials; for example, an article with a Nobel Laurette as an author is about 6 times more likely to get published without any significant comments compared to one by novice authors. This can be addressed by anonymizing...Read More
Double-Blinding Author Names Suggested to Address Bias in Peer-Review
Reviewers of papers submitted to journals can be biased towards authors with established credentials; for example, an article with a Nobel Laurette as an author is about 6 times more likely to get published without any significant comments compared to one by novice authors. This can be addressed by anonymizing the...Read More
Harmonization of Clinical Trial Rules for Private and Public Funded Clinical Trials
Reviewers of papers submitted to journals can be biased towards authors with established credentials; for example, an article with a Nobel Laurette as an author is about 6 times more likely to get published without any significant comments compared to one by novice authors. This can be addressed by anonymizing...Read More
